Login:
 
Barclay C. Combined oral contraceptive pill lowers ovarian cancer risk. Practitioner Oct 2018;262(1819):5

Combined oral contraceptive pill lowers ovarian cancer risk

22 Oct 2018Pais-up subscribers

Women who use the combined oral contraceptive pill (COCP) are at reduced risk of developing ovarian cancer, a benefit that persists for several years after cessation, a nationwide cohort study from Denmark has found.

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .